Patents by Inventor Michael Libman

Michael Libman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions and methods of using the same
    Patent number: 11911502
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: February 27, 2024
    Assignee: NODEN PHARMA DESIGNATED ACTIVITY COMPANY
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 11738015
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: August 29, 2023
    Assignee: NODEN PHARMA DESIGNATED ACTIVITY COMPANY
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 11040032
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: June 22, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10987347
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: April 27, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10973811
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: April 13, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10933060
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: March 2, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10894012
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: January 19, 2021
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10857095
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: December 8, 2020
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10420760
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: September 24, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10413505
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: September 17, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10231961
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: March 19, 2019
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
    Publication number: 20190060302
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Application
    Filed: October 30, 2018
    Publication date: February 28, 2019
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10149843
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: February 7, 2017
    Date of Patent: December 11, 2018
    Assignee: GNEUS LIFESCINECES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 10016407
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: July 10, 2018
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Pharmaceutical compositions and methods of using the same
    Patent number: 9867815
    Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: January 16, 2018
    Assignee: GENUS LIFESCIENCES INC.
    Inventors: Jeffrey M. Moshal, Michael Libman
  • Diversion- and/or abuse-resistant compositions and methods for making the same
    Patent number: 9649282
    Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: May 16, 2017
    Assignee: Invincible Biotechnology, LLC
    Inventors: Vadim Zolotarsky, Alexandr Vasilievich Troitsky, Michael Libman, Mikhail Viktorovich Losev
  • Diversion - And/Or Abuse-Resistant Compositions And Methods For Making The Same
    Publication number: 20150335593
    Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.
    Type: Application
    Filed: August 5, 2015
    Publication date: November 26, 2015
    Applicant: Invincible Biotechnology, LLC
    Inventors: Vadim ZOLOTARSKY, Alexandr Vasilievich TROITSKY, Michael LIBMAN, Mikhail Viktorovich LOSEV
  • Diversion- and/or abuse-resistant compositions and methods for making the same
    Patent number: 9125867
    Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: September 8, 2015
    Assignee: Invincible Biotechnology
    Inventors: Mikhail Viktorovich Losev, Alexandr Vasilievich Troitsky, Michael Libman, Vadim Zolotarsky
  • Diversion- and/or abuse-resistant aompositions and methods for making the same
    Publication number: 20110207761
    Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.
    Type: Application
    Filed: February 24, 2010
    Publication date: August 25, 2011
    Inventors: Mikhail Viktorovich Losev, Alexandr Vasilievich Troisky, Michael Libman, Vadim Zolotarsky
  • Composition including sea buckthorn oil extract and antioxidant and/or a UV filter
    Patent number: 6524561
    Abstract: A composition that includes Sea Buckthorn Oil may be used as a cosmetic product, a pharmaceutical or nutraceutical product or a food product. The composition maintains its distinctive color, due to the use of Sea Buckthorn Oil, over time, even when exposed to oxygen and/or U.V. light. The color of Sea Buckthorn Oil is maintained by adding to the composition Sea Buckthorn Oil in an amount from 0.01 to 90% by weight and an antioxidant and/or a U.V. filter in an amount from 0.001 to 20% by weight.
    Type: Grant
    Filed: December 12, 2000
    Date of Patent: February 25, 2003
    Assignee: Altai Cosmetics, Ltd.
    Inventors: Michael Libman, Vadim Zolotarsky